Why the study?
Are external loop recorders more cost-effective than Holter monitoring for ambulatory monitoring of "community acquired" syncope?
Are external loop recorders more cost-effective than Holter monitoring for ambulatory monitoring of "community acquired" syncope?
The net benefit regression framework provides a straightforward method for constructing cost-effectiveness acceptability curves in clinical trials.
NBRF simplifies CEAC construction in cost-effectiveness analyses; leaves open adoption for syncope monitoring decisions without further validation.
The NBRF is straightforward to use and interpret. The resulting uncertainty surrounding the regression coefficient relates to the CEAC. When the link from the regression's p-value to the probability of cost-effectiveness is tentative, bootstrapping may be used.
No takes yet. Share an insight, caveat, or question.
Hoch et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: